Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Associations between endogenous dimethylarginines and renal function in healthy children and adolescents.

Jaźwińska-Kozuba A, Martens-Lobenhoffer J, Surdacki A, Kruszelnicka O, Rycaj J, Godula-Stuglik U, Bode-Böger SM.

Int J Mol Sci. 2012 Nov 21;13(11):15464-74. doi: 10.3390/ijms131115464.

2.

HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.

Ivanova M, Artusi C, Boffa GM, Zaninotto M, Plebani M.

Clin Chim Acta. 2010 Nov 11;411(21-22):1632-6. doi: 10.1016/j.cca.2010.06.001. Epub 2010 Jun 11.

PMID:
20542018
3.

Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.

Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.

Transl Res. 2013 Aug;162(2):67-76. doi: 10.1016/j.trsl.2013.04.005. Epub 2013 May 22.

PMID:
23707198
4.

Methylated arginine derivatives in children and adolescents with chronic kidney disease.

Brooks ER, Langman CB, Wang S, Price HE, Hodges AL, Darling L, Yang AZ, Smith FA.

Pediatr Nephrol. 2009 Jan;24(1):129-34. doi: 10.1007/s00467-008-0972-1. Epub 2008 Oct 2.

PMID:
18830716
5.

Comparison of symmetric dimethylarginine with creatinine, cystatin C and their eGFR equations as markers of kidney function.

El-Khoury JM, Bunch DR, Hu B, Payto D, Reineks EZ, Wang S.

Clin Biochem. 2016 Oct;49(15):1140-1143. doi: 10.1016/j.clinbiochem.2016.07.009. Epub 2016 Jul 21.

PMID:
27452178
6.

Nitric oxide synthase inhibitors and hypertension in children and adolescents.

Goonasekera CD, Rees DD, Woolard P, Frend A, Shah V, Dillon MJ.

J Hypertens. 1997 Aug;15(8):901-9.

PMID:
9280214
7.

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.

Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G.

Kidney Int Suppl. 2001 Feb;78:S14-8.

PMID:
11168976
8.

Estimated GFR is biased by non-traditional cardiovascular risk factors.

Melsom T, Fuskevåg OM, Mathisen UD, Strand H, Schei J, Jenssen T, Solbu M, Eriksen BO.

Am J Nephrol. 2015;41(1):7-15. doi: 10.1159/000371557. Epub 2015 Jan 23.

PMID:
25612475
9.

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans.

Nijveldt RJ, Van Leeuwen PA, Van Guldener C, Stehouwer CD, Rauwerda JA, Teerlink T.

Nephrol Dial Transplant. 2002 Nov;17(11):1999-2002.

PMID:
12401860
10.

Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.

Cavalca V, Veglia F, Squellerio I, De Metrio M, Rubino M, Porro B, Moltrasio M, Tremoli E, Marenzi G.

PLoS One. 2012;7(11):e48499. doi: 10.1371/journal.pone.0048499. Epub 2012 Nov 19.

11.

Dimethylarginines as risk markers of atherosclerosis and chronic kidney disease in children with nephrotic syndrome.

Hyla-Klekot L, Bryniarski P, Pulcer B, Ziora K, Paradysz A.

Adv Clin Exp Med. 2015 Mar-Apr;24(2):307-14. doi: 10.17219/acem/40465.

12.

Accumulation of symmetric dimethylarginine in hepatorenal syndrome.

Lluch P, Mauricio MD, Vila JM, Segarra G, Medina P, Del Olmo JA, Rodrigo JM, Serra MA.

Exp Biol Med (Maywood). 2006 Jan;231(1):70-5.

PMID:
16380646
14.

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.

Fleck C, Schweitzer F, Karge E, Busch M, Stein G.

Clin Chim Acta. 2003 Oct;336(1-2):1-12. Review.

PMID:
14500028
15.

Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry.

Wang S, Vicente FB, Miller A, Brooks ER, Price HE, Smith FA.

Clin Chem Lab Med. 2007;45(10):1305-12.

PMID:
17663630
16.
17.

L-Arginine Derivatives Are Associated with the Hyperthyroid State in the General Population.

Ittermann T, Bahls M, Atzler D, Friedrich N, Schwedhelm E, Böger RH, Felix SB, Völzke H, Dörr M.

Thyroid. 2016 Feb;26(2):212-8. doi: 10.1089/thy.2015.0385. Epub 2015 Dec 28.

PMID:
26650143
18.

Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.

Ronden RA, Houben AJ, Teerlink T, Bakker JA, Bierau J, Stehouwer CD, De Leeuw PW, Kroon AA.

Am J Physiol Renal Physiol. 2012 Jul 1;303(1):F149-56. doi: 10.1152/ajprenal.00045.2012. Epub 2012 May 2.

19.

Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension.

Henrohn D, Sandqvist A, Egeröd H, Hedeland M, Wernroth L, Bondesson U, Wikström G.

Vascul Pharmacol. 2015 Oct;73:71-7. doi: 10.1016/j.vph.2015.04.010. Epub 2015 Apr 29.

PMID:
25934511
20.

Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes.

Marcovecchio ML, Dalton RN, Turner C, Prevost AT, Widmer B, Amin R, Dunger DB.

Arch Dis Child. 2010 Feb;95(2):119-24. doi: 10.1136/adc.2009.158394. Epub 2009 Nov 29.

PMID:
19948509

Supplemental Content

Support Center